Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Int J Cancer. 2019 Jun 1;144(11):2651-2668. doi: 10.1002/ijc.31997. Epub 2019 Jan 7.
Whether sunscreen use affects melanoma risk has been widely studied with contradictory results. To answer this question we performed a systematic review of all published studies, accounting for sources of heterogeneity and bias. We searched for original articles investigating the sunscreen-melanoma association in humans to February 28, 2018. We then used random-effects meta-analysis to combine estimates of the association, stratified by study design. Stratified meta-analysis and meta-regression were used to identify sources of heterogeneity. We included 21,069 melanoma cases from 28 studies published 1979-2018: 23 case-control (11 hospital-based, 12 population-based), 1 ecological, 3 cohort and 1 randomised controlled trial (RCT). There was marked heterogeneity across study designs and among case-control studies but adjustment for confounding by sun exposure, sunburns and phenotype systematically moved estimates toward decreased melanoma risk among sunscreen users. Ever- vs. never-use of sunscreen was inversely associated with melanoma in hospital-based case-control studies (adjusted odds ratio (OR) = 0.57, 95%confidence interval (CI) 0.37-0.87, p < 0.001), the ecological study (rate ratio = 0.48, 95%CI 0.35-0.66), and the RCT (hazard ratio (HR) = 0.49, 95%CI 0.24-1.01). It was not associated in population-based case-control studies (OR = 1.17, 95%CI 0.90-1.51, p < 0.001) and was positively associated in the cohort studies (HR = 1.27, 95%CI 1.07-1.51, p = 0.236). The association differed by latitude (p = 0.042), region (p = 0.008), adjustment for naevi/freckling (p = 0.035), and proportion of never-sunscreen-users (p = 0·012). Evidence from observational studies on sunscreen use and melanoma risk was weak and heterogeneous, consistent with the challenges of controlling for innate confounding by indication. The only RCT showed a protective effect of sunscreen.
防晒霜的使用是否会影响黑色素瘤的风险,这一问题已经进行了广泛的研究,但结果却相互矛盾。为了回答这个问题,我们系统地回顾了所有已发表的研究,考虑了异质性和偏倚的来源。我们检索了截至 2018 年 2 月 28 日,调查人类使用防晒霜与黑色素瘤之间关联的原始文章。然后,我们使用随机效应荟萃分析来合并研究设计分层的关联估计。分层荟萃分析和荟萃回归用于确定异质性的来源。我们纳入了 28 项研究中的 21069 例黑色素瘤病例,这些研究发表于 1979 年至 2018 年:23 项病例对照研究(11 项基于医院,12 项基于人群),1 项生态学研究,3 项队列研究和 1 项随机对照试验(RCT)。研究设计和病例对照研究之间存在明显的异质性,但对阳光暴露、晒伤和表型的混杂因素进行调整,系统地将估计值向防晒霜使用者黑色素瘤风险降低的方向移动。与从不使用防晒霜相比,曾经使用防晒霜与黑色素瘤呈负相关,在基于医院的病例对照研究中(调整后的比值比(OR)=0.57,95%置信区间(CI)0.37-0.87,p<0.001),生态学研究(比率比=0.48,95%CI 0.35-0.66)和 RCT(风险比(HR)=0.49,95%CI 0.24-1.01)。在基于人群的病例对照研究中,这两者没有相关性(OR=1.17,95%CI 0.90-1.51,p<0.001),在队列研究中则呈正相关(HR=1.27,95%CI 1.07-1.51,p=0.236)。这种相关性因纬度(p=0.042)、地区(p=0.008)、痣/雀斑的调整(p=0.035)和从不使用防晒霜者的比例(p=0.012)而异。来自观察性研究的关于防晒霜使用与黑色素瘤风险的证据是微弱和异质的,这与控制内在指示性混杂因素的挑战一致。唯一的 RCT 显示防晒霜有保护作用。